Optimi Health Corp
Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of m… Read more
Optimi Health Corp (OPTHF) - Net Assets
Latest net assets as of September 2025: $6.57 Million USD
Based on the latest financial reports, Optimi Health Corp (OPTHF) has net assets worth $6.57 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.21 Million) and total liabilities ($8.64 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.57 Million |
| % of Total Assets | 43.19% |
| Annual Growth Rate | 4.44% |
| 5-Year Change | -68.81% |
| 10-Year Change | N/A |
| Growth Volatility | 129.5 |
Optimi Health Corp - Net Assets Trend (2020–2025)
This chart illustrates how Optimi Health Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Optimi Health Corp (2020–2025)
The table below shows the annual net assets of Optimi Health Corp from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $6.57 Million | -31.38% |
| 2024-09-30 | $9.58 Million | -27.52% |
| 2023-09-30 | $13.21 Million | -17.54% |
| 2022-09-30 | $16.02 Million | -23.96% |
| 2021-09-30 | $21.07 Million | +298.44% |
| 2020-09-30 | $5.29 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Optimi Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2707245900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $33.81 Million | 514.60% |
| Total Equity | $6.57 Million | 100.00% |
Optimi Health Corp Competitors by Market Cap
The table below lists competitors of Optimi Health Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EMB Mission Bound AB (publ)
ST:NAVIGO-STAM
|
$9.73 Million |
|
Mtag Group Berhad
KLSE:0213
|
$9.73 Million |
|
Cubic Korea Inc
KQ:021650
|
$9.73 Million |
|
Royal Plus PCL
BK:PLUS
|
$9.73 Million |
|
Tennessee Valley Financial Holdings Inc
PINK:TVLF
|
$9.73 Million |
|
Ostasiatiske Kompagni A/S
CO:OKEAC
|
$9.73 Million |
|
5TH PLANET GAMES DK -50
F:2HG1
|
$9.73 Million |
|
Samil Co.Ltd
KQ:032280
|
$9.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Optimi Health Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 9,575,712 to 6,570,661, a change of -3,005,051 (-31.4%).
- Net loss of 3,712,031 reduced equity.
- New share issuances of 395,000 increased equity.
- Other factors increased equity by 311,980.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.71 Million | -56.49% |
| Share Issuances | $395.00K | +6.01% |
| Other Changes | $311.98K | +4.75% |
| Total Change | $- | -31.38% |
Book Value vs Market Value Analysis
This analysis compares Optimi Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.91x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 1.70x to 1.91x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-09-30 | $0.08 | $0.13 | x |
| 2021-09-30 | $0.30 | $0.13 | x |
| 2022-09-30 | $0.20 | $0.13 | x |
| 2023-09-30 | $0.15 | $0.13 | x |
| 2024-09-30 | $0.10 | $0.13 | x |
| 2025-09-30 | $0.07 | $0.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Optimi Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -56.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -870.75%
- • Asset Turnover: 0.03x
- • Equity Multiplier: 2.32x
- Recent ROE (-56.49%) is below the historical average (-46.66%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -28.57% | 0.00% | 0.00x | 1.11x | $-8.13 Million |
| 2022 | -45.89% | -9106.91% | 0.00x | 1.05x | $-8.95 Million |
| 2023 | -39.32% | -2868.54% | 0.01x | 1.25x | $-6.52 Million |
| 2024 | -63.03% | -1548.25% | 0.03x | 1.52x | $-6.99 Million |
| 2025 | -56.49% | -870.75% | 0.03x | 2.32x | $-4.37 Million |
Industry Comparison
This section compares Optimi Health Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Optimi Health Corp (OPTHF) | $6.57 Million | -28.57% | 1.32x | $9.73 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |